A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Relapsed/Refractory Multiple Myeloma
Related studies linked through entity extraction aliases.
Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- NA
LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
- Status
- RECRUITING
- Phase
- NA
A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE3
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A